Dr. Lekshmi r.Nath – Non alcoholic fatty liver -hepatocellular carcinoma – Women Researcher Award

Dr. Lekshmi r.Nath - Non alcoholic fatty liver -hepatocellular carcinoma - Women Researcher Award

Amrita Vishwa vidyapeetham - India

Author Profile 

SCOPUS

ORCID

Early academic pursuits 🎓

Dr. Lekshmi r.Nath embarked on her academic journey in pharmaceutical sciences with a b.pharm degree from mahatma gandhi university, india. her passion for natural products and their medicinal properties led her to pursue an m.pharm in pharmacognosy from rajiv gandhi university of health sciences. she further specialized in biotechnology, earning her ph.d. from the rajiv gandhi centre for biotechnology, kerala, where her research focused on evaluating the anticancer effects of active principles from solanum nigrum linn and chromolaena odorata.

Professional endeavors 🏢

currently an associate professor in the department of pharmacognosy at the amrita school of pharmacy, dr. lekshmi has established herself as a dedicated educator and researcher. her professional journey is marked by her contributions to the field of pharmacognosy, particularly in the exploration of natural products for therapeutic applications. her teaching and mentorship have influenced many students and researchers in the field of pharmaceutical sciences.

Contributions and research focus 🔬

dr. lekshmi's research is centered on the discovery and development of natural products with therapeutic potential. her ph.d. research led to the identification of uttroside b, a compound with significant anticancer properties, particularly against hepatocellular carcinoma. her work extends Non alcoholic fatty liver -hepatocellular carcinoma to both in vitro and in vivo studies, providing a strong foundation for the therapeutic application of natural products. her innovative approach to pharmacognosy continues to contribute valuable insights into the field.

Accolades and recognition 🏅

dr. lekshmi's research has been recognized globally, particularly her work on uttroside b, which has received both u.s. and canadian patents. the significance of her findings was further acknowledged when the fda granted orphan drug designation to uttroside b for the treatment of Non alcoholic fatty liver -hepatocellular carcinoma hepatocellular carcinoma. these accolades underscore her impact in the field of cancer research and her contribution to the development of novel therapeutics.

Impact and influence 🌍

through her research, dr. lekshmi has made a profound impact on the field of pharmacognosy and cancer therapeutics. her discovery of Non alcoholic fatty liver -hepatocellular carcinoma uttroside b offers a new avenue for the treatment of hepatocellular carcinoma, potentially improving outcomes for patients with this challenging disease. her work not only advances scientific knowledge but also has the potential to make a tangible difference in the lives of those affected by cancer.

Legacy and future contributions 🔮

dr. lekshmi's legacy is rooted in her pioneering research on natural products and their application in cancer therapy. her work on uttroside b sets the stage for future research and development in the field, with the potential to lead to new treatments for cancer. as she continues her work, dr. lekshmi is poised to make further contributions to the understanding and use of natural products in medicine, inspiring future generations of researchers.

Notable Publications

Assoc Prof Dr. Hany fayed – kidney injury – liver fibrosis -Best Researcher Award

Assoc Prof Dr. Hany fayed - kidney injury - liver fibrosis -Best Researcher Award

National Research Centre - Egypt

Author Profile

SCOPUS

ORCID

Early academic pursuits 🎓

hany moawad ali fayed embarked on his academic journey with a solid foundation in veterinary medicine. he earned his bachelor’s degree in veterinary medical sciences from menofiya university in 2007, graduating with a very good cumulative grade. his pursuit of advanced knowledge led him to cairo university, where he obtained his master’s degree in veterinary pharmacology in 2013. his master’s thesis explored the hepatoprotective effects of artichoke extract against precancerous lesions in rats. furthering his expertise, he completed his phd in veterinary pharmacology at cairo university in 2017, with his research focusing on evaluating osteopontin in experimentally induced liver fibrosis in rats.

Professional endeavors 🏛️

dr. fayed’s professional career has been marked by his roles in both teaching and research. from 2012 to 2022, he conducted and taught training courses on pharmacological and toxicological experiments and animal handling at cairo university’s faculty of pharmacy. his research career began as an assistant researcher at the national research centre’s department of pharmacology from 2015 to 2018. he then advanced to a researcher position from 2018 to 2023, and has been serving as an associate professor since july 2023. in these roles, he has contributed significantly to various research projects and collaborations, focusing on pharmacology and toxicology.

Contributions and research focus 🔬

dr. fayed’s research contributions are substantial, particularly in the field of pharmacology. he has led and participated in multiple projects, including a study on the therapeutic effects of canagliflozin and linagliptin against hepatocarcinogenesis in rats, funded by the national research centre. his work also includes investigating new therapies for liver fibrosis and hepatoprotective activities of egyptian sansevieria species. his kidney injury - liver fibrosis involvement in nano toxicological and pharmacological assessments of nano gold materials highlights his commitment to advancing cancer diagnosis and therapy.

Accolades and recognition 🏆

dr. fayed has been recognized for his exceptional research and academic contributions. in 2017-2018, he was awarded the national research centre prize for the best phd thesis in the medical division. his active participation in conferences and workshops, including the 14th kidney injury - liver fibrosis international phytocosmetics and phytotherapy congress, further demonstrates his commitment to advancing scientific knowledge and fostering collaboration in his field.

Impact and influence 🌍

dr. fayed’s work has had a significant impact on the field of pharmacology, particularly in the areas of liver disease and cancer research. his research on hepatoprotective agents and liver fibrosis contributes to the development of new therapeutic strategies, while his involvement in kidney injury - liver fibrosis high-profile research projects and conferences helps shape the direction of future studies in pharmacology and toxicology.

Legacy and future contributions 🔮

looking ahead, dr. fayed is poised to continue his impactful work in pharmacology and toxicology. his ongoing projects and research efforts aim to enhance understanding of liver diseases and develop novel therapeutic approaches. his dedication to both research and education ensures that his contributions will have a lasting effect on the field, influencing future research and training in pharmacology and related disciplines.

Notable Publications